MedTrace Logo

Atorvastatin Effects On Arterial Stiffness In Hemodialysis

NCT04472637 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2022-04-15

No results posted yet for this study

Summary

This research aims to assess effects of atorvastatin on arterial stiffness in hemodialysis patients

Conditions

  • Arterial Stiffness

Interventions

DRUG

Atorvastatin

atorvastatin 10 mg, as one tablet /day for 24 weeks.

DRUG

Placebo

a placebo in the form of multivitamin tablets similar to the experimental drugs with the same regimen (one tablet /day for 24 weeks)

Sponsors & Collaborators

  • Alexandria University

    lead OTHER

Principal Investigators

  • Mohamed Mamdouh Elsayed, MD · lecturer

  • El Hassan M Ayman, MSc · Assistant lecturer

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-01
Primary Completion
2021-05-01
Completion
2021-07-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04472637 on ClinicalTrials.gov